CLASSYS reports higher quarterly revenue on overseas growth
Overseas growth supported CLASSYS's second-quarter revenue, while net income declined and costs from direct overseas operations were reflected in consolidated results.

CLASSYS, a maker of aesthetic medical devices, said its second-quarter revenue rose 26.7 percent to 106 billion won ($74.6 million) from 83.3 billion won a year earlier, helped by broad-based overseas growth and a contribution from its South American entity.
The company said growth was spread across major overseas markets including Europe, North America, Thailand and the Commonwealth of Independent States.
Operating profit rose 2.2 percent to 43.9 billion won ($31 million) from 43 billion won a year earlier, while net income fell 3.6 percent to 25.5 billion won ($18 million) from 26.5 billion won.
Ultraformer recorded its highest global quarterly sales, CLASSYS said. Volnewmer maintained high sales, while Quadsays sales expanded and European demand for laser equipment increased. The overseas consumables business grew 32.6 percent from a year earlier as the company expanded its equipment sales base.
Operating margin at CLASSYS headquarters exceeded 50 percent during the second quarter. Consolidated results included overseas operating costs associated with the shift to direct operations in South America and Japan.
“In the second half, we will further strengthen execution on core tasks, including package promotions to strengthen domestic market leadership, as well as simultaneous B2B and B2C marketing to turn around the Latin American business,” a CLASSYS official said.
What this article is based on
Every fact in this article can be checked against the primary documents below.
- Regulatory filing클래시스 연결재무제표기준영업(잠정)실적(공정공시)· DART· accessed Aug. 12, 2026
- Other하반기 계획· classys.co.kr· accessed Aug. 12, 2026
- Regulatory filing주력 사업· DART· accessed Aug. 12, 2026
© New Era Korea Daily. All rights reserved.
More in Companies
- Alteogen to absorb biolabs unit in small-scale merger
- Alteogen to absorb biologics unit in all-stock merger
- HD Hyundai unit wins 338 billion won coal yard contract from Korea Midland Power
- HD Korea Shipbuilding wins 338 billion won Boryeong coal-yard contract
- EOFlow raises 500 million won as trading halt persists